-
Something wrong with this record ?
HIF signaling pathway in pheochromocytoma and other neuroendocrine tumors
I. Jochmanová, T. Zelinka, J. Widimský, K. Pacak
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Hypoxia-Inducible Factor 1, alpha Subunit metabolism MeSH
- Pheochromocytoma genetics metabolism pathology MeSH
- Humans MeSH
- Adrenal Gland Neoplasms genetics metabolism pathology MeSH
- Neuroendocrine Tumors genetics metabolism pathology MeSH
- Prognosis MeSH
- Signal Transduction * MeSH
- Basic Helix-Loop-Helix Transcription Factors genetics metabolism MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Hypoxia-inducible factors (HIFs) are transcription factors controlling energy, iron metabolism, erythropoiesis, and development. Dysregulation of these proteins contributes to tumorigenesis and cancer progression. Recent findings revealed the important role of HIFs in the pathogenesis of neuroendocrine tumors, especially pheochromocytoma (PHEO) and paraganglioma (PGL). PHEOs and PGLs are catecholamine-producing tumors arising from sympathetic- or parasympathetic-derived chromaffin tissue. To date, eighteen PHEO/PGL susceptibility genes have been identified. Based on the main signaling pathways, PHEOs/PGLs have been divided into two clusters, pseudohypoxic cluster 1 and cluster 2, rich in kinase receptor signaling and protein translation pathways. Recent data suggest that both clusters are interconnected via the HIF signaling and its role in tumorigenesis is supported by newly described somatic and germline mutations in HIF2A gene in patients with PHEOs/PGLs associated with polycythemia, and in some of them also with somatostatinoma. Moreover, HIFalpha signaling has also been shown to be upregulated in neuroendocrine tumors other than PHEO/PGL. Some of these tumors are components of hereditary tumor syndromes which can be associated with PHEO/PGL, but also in ileal carcinoids or melanoma. HIF signaling appears to be one of the crucial players in tumorigenesis, which could suggest new therapeutic approaches for treatment of neuroendocrine tumors.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15008964
- 003
- CZ-PrNML
- 005
- 20170106084342.0
- 007
- ta
- 008
- 150305s2014 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.932789 $2 doi
- 035 __
- $a (PubMed)24908231
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Jochmanová, Ivana. $u Department of Internal Medicine, Faculty of Medicine, P. J. Šafárik University, Košice, Slovakia; Section on Medical Neuroendocrinology, Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver NICHD, NIH, Bethesda, MD, USA. karel@mail.nih.gov. $7 xx0267304
- 245 10
- $a HIF signaling pathway in pheochromocytoma and other neuroendocrine tumors / $c I. Jochmanová, T. Zelinka, J. Widimský, K. Pacak
- 520 9_
- $a Hypoxia-inducible factors (HIFs) are transcription factors controlling energy, iron metabolism, erythropoiesis, and development. Dysregulation of these proteins contributes to tumorigenesis and cancer progression. Recent findings revealed the important role of HIFs in the pathogenesis of neuroendocrine tumors, especially pheochromocytoma (PHEO) and paraganglioma (PGL). PHEOs and PGLs are catecholamine-producing tumors arising from sympathetic- or parasympathetic-derived chromaffin tissue. To date, eighteen PHEO/PGL susceptibility genes have been identified. Based on the main signaling pathways, PHEOs/PGLs have been divided into two clusters, pseudohypoxic cluster 1 and cluster 2, rich in kinase receptor signaling and protein translation pathways. Recent data suggest that both clusters are interconnected via the HIF signaling and its role in tumorigenesis is supported by newly described somatic and germline mutations in HIF2A gene in patients with PHEOs/PGLs associated with polycythemia, and in some of them also with somatostatinoma. Moreover, HIFalpha signaling has also been shown to be upregulated in neuroendocrine tumors other than PHEO/PGL. Some of these tumors are components of hereditary tumor syndromes which can be associated with PHEO/PGL, but also in ileal carcinoids or melanoma. HIF signaling appears to be one of the crucial players in tumorigenesis, which could suggest new therapeutic approaches for treatment of neuroendocrine tumors.
- 650 _2
- $a nádory nadledvin $x genetika $x metabolismus $x patologie $7 D000310
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a transkripční faktory bHLH $x genetika $x metabolismus $7 D051792
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a faktor 1 indukovatelný hypoxií - podjednotka alfa $x metabolismus $7 D051795
- 650 _2
- $a neuroendokrinní nádory $x genetika $x metabolismus $x patologie $7 D018358
- 650 _2
- $a feochromocytom $x genetika $x metabolismus $x patologie $7 D010673
- 650 _2
- $a prognóza $7 D011379
- 650 12
- $a signální transdukce $7 D015398
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Zelinka, Tomáš $7 xx0074465 $u Third Department of Medicine, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Widimský, Jiří, $d 1956- $7 jn99240001422 $u Third Department of Medicine, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Pacák, Karel, $d 1958- $7 jo20000074102 $u Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, USA
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 63, Suppl. 2 (2014), s. S251-S262
- 773 0_
- $t Professor Schreiber celebrates his 90th birthday $g (2014), s. S251-S262 $w MED00190346
- 856 41
- $u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20150305 $b ABA008
- 991 __
- $a 20170106084434 $b ABA008
- 999 __
- $a ok $b bmc $g 1066878 $s 891767
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 63 $c Suppl. 2 $d S251-S262 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- BMC ##
- $a 2014 $d S251-S262 $m Professor Schreiber celebrates his 90th birthday $x MED00190346
- LZP __
- $b NLK118 $a Pubmed-20150305